Although vascularization may require several days to complete, G-CSF might accelerate the process through mobilization of EPCs or preservation of endogenous endothelial cells, allowing the preservation of a patent vasculature not only to prevent delayed tPA-induced HT but also to produce neurologic and functional outcome improvements after stroke [3,4]. This evidence concerns the gene CSF3 and hematocrit.